dc.contributor.author | Engin CD,Ekinci UB,Selver A,Saatçi AO | |
dc.date.accessioned | 2023-03-02T11:25:39Z | |
dc.date.available | 2023-03-02T11:25:39Z | |
dc.date.issued | 2020 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12481/16264 | |
dc.description.abstract | The aim of this study was to report the outcome of topical brinzolamide 1% treatment on macular cystoid lesions resembling retinoschisis in 4 patients diagnosed with posterior microphthalmia. The medical records of 4 patients with a clinical diagnosis of posterior microphthalmia who had started topical brinzolamide 1% treatment were reviewed. Visual acuity, central foveal thickness, and cystoid lesion area percentage were used to evaluate treatment response. In the follow-up, there was a decrease in central foveal thicknesses and cystoid lesion area percentages in both eyes of 3 of the patients. However, 1 patient showed increases in both parameters. Visual acuity remained stable in 5 eyes and increased in 3 eyes. Topical brinzolamide treatment may have some positive effects on macular cystoid lesions in selected cases. © 2020 by Turkish Ophthalmological Association Turkish Journal of Ophthalmology, published by Galenos Publishing House. | |
dc.title | Efficacy of topical brinzolamide treatment in posterior microphthalmos-related macular cystoid lesions: A case series | |
dc.identifier.DOI-ID | 10.4274/tjo.galenos.2019.40504 | |
dc.identifier.volume | 50 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 44 | |
dc.identifier.endpage | 49 | |
dc.identifier.issn/e-issn | 2149-8709 | |